Differential Impact of Prognostically Significant Gene Mutations in Acute Myeloid Leukemia (AML) Patients (Pts) Older Than 70 Years (y) Treated With a Cytarabine-Based Induction Therapy (Alliance)
- Citation:
- Blood vol 136 (Supplement 1) 40-1
- Meeting Instance:
- ASH 2020
- Year:
- 2020
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- TRP
- Primary Committee:
- Leuk Corr Sci
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821, U10CA180882 U24CA196171;
- Corr. Author:
- Authors:
- Marius Bill Jessica Kohlschmidt Krzysztof Mrózek Deedra Nicolet Christopher J. Walker Dimitrios Papaioannou James Blachly Shelley Orwick Eunice S. Wang Jonathan E. Kolitz Bayard L. Powell Andrew J. Carroll Ramiro Garzon Richard M. Stone John C Byrd Clara D. Bloomfield Ann-Kathrin Eisfeld
- Networks:
- CT063, LAPS-AL002, LAPS-MA036, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL, OH070
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-20202, CALGB-8461, CALGB-9665
- Phases:
- N/A
- Keywords: